Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY:SYK)

395.63 +2.92 (+0.74%)
Official Closing Price Updated: 7:00 PM EDT, Jun 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Stryker Corp

< Previous 1 2 3 4 Next >
The Value Deepens for Medtech Stocks: Reversal Imminent
MedTech stocks are performing well and supported by pent-up demand, yet share prices are trading at significant and often historical lows. 
Via MarketBeat
Over 2,400 Surgical Cases Completed Using Stryker’s Q Guidance System with Spine Guidance Software in First Year
From Stryker
Via Business Wire
Stryker to host investor day
From Stryker Corporation
Via GlobeNewswire
Stryker to announce financial results for its third quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions
From Stryker
Via Business Wire
Stryker’s Pangea Systems Receive FDA Clearance
From Stryker
Via Business Wire
How Artificial Intelligence is Bolstering Impressive Billion Dollar Growth Opportunities in Healthcare Sector
EQNX::TICKER_START (NASDAQ:DPRO),(CSE:DPRO),(NYSE:IBM),(NASDAQ:GOOG),(NYSE:MDT),(NYSE:SYK) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
AMC Stock: The Horror Film Traders Keep Showing Up For
Just as AMC’s profitability was starting to improve, the dilution train has once again derailed traders' hopes of a turnaround. 
Via MarketBeat
16 Top Robotics Companies to Get to Know in 2023
What are the top robotics companies in the USA, as robotics continues to grow? Learn more about the best companies today with MarketBeat. 
Via MarketBeat
Topics Artificial Intelligence
A Significant Reversal is in Sight for These 5 Med Tech Companies
Med tech stocks are down YOY despite strong secular tailwinds, cash flow, and dividends; the downturn in action is an opportunity and reversal is at hand. 
Via MarketBeat
5 Good Reasons it's Time to Buy High-Yield Dividend King 3M
3M settled the ear plug lawsuit, clearing the path forward. The stock offers investors a high yield and value that may be too hard to pass up 
Via MarketBeat
Topics Lawsuit
Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference
From Stryker Corporation
Via GlobeNewswire
Stryker reports second quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker Announces Commercial Launch of Q Guidance System With Cranial Guidance Software
From Stryker
Via Business Wire
Bullish Action: Chipotle, Visa, Stryker Break Through Resistance
Chipotle, Visa, and Stryker recently broke out of chart bases, and remain in buy range on strong fundamental growth, institutional buying and analyst upgrades. 
Via MarketBeat
Stryker to announce financial results for its second quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
DexCom Clears Base, Wall Street Eyes Double-Digit Earnings Growth
DexCom's G7 glucose-monitoring solution is driving revenue growth at the company. Analysts expect strong double-digit EPS growth this year and next. 
Via MarketBeat
Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs
Intuitive Surgical (NASDAQ: ISRG) manufactures the revolutionary da Vinci Surgical System, the leader in robotic-assisted surgery systems. Da Vinci is turning 
Via MarketBeat
Surgeons Successfully Complete First Surgical Cases Using Stryker’s Q Guidance System with Cranial Guidance Software
From Stryker
Via Business Wire
Microbot Medical spikes 150% on its Endovascular Surgical Robot
Microbot Medical Inc. (NASDAQ: MBOT) stock spiked more than 150% on a massive 194 million share volume on a successful pre-clinical animal study for its LIBERT 
Via MarketBeat
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
Stryker reports first quarter 2023 operating results
From Stryker Corporation
Via GlobeNewswire
Healthcare Innovation Drives Medical Device Makers To New Highs
Medical products makers Stryker and Boston Scientific are rallying to all-time highs, while sector peer DexCom is forming a constructive base. 
Via MarketBeat
Stryker to announce financial results for its first quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
From Stryker
Via Business Wire
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
Are These Medical Device Makers Getting Ready To Rally?
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
Via MarketBeat
Stryker’s Q Guidance System for cranial applications receives FDA clearance
From Stryker
Via Business Wire
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.